Anatara Lifesciences Ltd (ANR.AX)

0.0460 +0.0030 (+6.98%) At close: 04:10PM AEST

Anatara Lifesciences Ltd

81 Flinders Street
Level 8
Adelaide, SA 5000
Australia
61 4 3802 7172
https://anataralifesciences.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Dr. David Lionel Brookes F.A.C.I.D., FACRRM, FAICD, MBBS	Executive Chairman	168.21k	N/A	1960
Mr. John Michailidis B.Sc., EMBA, M.A.I.C.D.	COO & Executive Director	118.79k	N/A	N/A
Mr. Simon Erskine	Chief Development Officer	235.21k	N/A	N/A
Jane Lowe	Managing Director of IR Department	N/A	N/A	N/A
Dr. Stephen Denaro AGIA, BCom, CA, GradDipApp CG, MAICD	Company Secretary	N/A	N/A	N/A
Ms. Hayley van der Meer B Biomed Sc, Grad Dip Marketing Management	Commercial Manager	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Anatara Lifesciences Ltd engages in the research, development, and commercialization of evidence-based solutions for gastrointestinal diseases in animals and humans in Australia. It offers Gastrointestinal ReProgramming, a proprietary formulation that combines bromelain with other evidence-based ingredients to address the primary underlying factors associated with human gastrointestinal conditions, such as irritable bowel syndrome and inflammatory bowel disease. The company also provides Detach for the treatment of diarrhea disease in piglets; BONIFF, a revised formulation to dry feed for piglets after weaning; and ANR-pf, a proprietary formulation for poultry in water. Anatara Lifesciences Ltd was incorporated in 2010 and is based in Adelaide, Australia.

Corporate governance

Anatara Lifesciences Ltd’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.